In patients receiving long-term therapeutic or replacement corticosteroids, delayed or inappropriate adjustment of steroid dosage during intercurrent illness may be fatal. We used a questionnaire to assess current levels of patient knowledge, awareness of the need for action during intercurrent illness and the frequency with which steroid warning cards and Medic Alert pendants were carried, in 61 patients on long-term replacement corticosteroids and in 40 patients receiving long-term therapeutic corticosteroids.
Introduction
Corticosteroids have been used for many years to treat a wide range of acute and chronic illnesses. The suppressive effect of corticosteroids on the hypothalamic-pituitary-adrenal (HPA) axis varies from patient to patient.' Suppression of the HPA axis may occur after only 5 days therapy with high-dose corticosteroids2 and occurs with prolonged therapy at lower doses, although the exact dose, length of therapy and total dose required to do this is not easily evaluated. 3 In patients with HPA axis suppression induced by long-term corticosteroid therapy and in patients with either primary or secondary adrenal insufficiency, the normal stress-related increase in corticosteroid production will be impaired or absent. These patients are therefore at risk of adrenal crisis and death, should they not receive additional corticosteroids during intercurrent illness, surgery or similar physical stress. 46 Patients who are prescribed corticosteroids should be given a steroid warning card by the dispensing pharmacist or responsible clinician to alert the patient and any attending physician to the need for increased steroids during acute ill health. The wearing of Medic Alert bracelets or pendants may also serve this purpose.
We carried out a questionnaire-based survey of patients taking long-term replacement or therapeutic corticosteroids, in order to assess the frequency with which steroid warning cards and Medic Alert pendants were carried, and also to assess patient knowledge and awareness ofthe need for action during intercurrent illness.
Methods
A questionnaire was completed by 101 adult patients who had been taking corticosteroids for therapeutic (n = 41) or replacement (n = 60) indications continuously in any dose for longer than 2 months. Patients were interviewed in general medical, rheumatology and endocrinology outpatient departments at Leeds General Infirmary by the clinic doctor. Answers were either of a Yes/No type or there was a choice of responses.
Patients were asked if they had ever been given a steroid warning card or were owners ofMedic Alert pendants -proof of carrying either of these was requested at interview. They were also asked ifthey had ever received advice regarding their steroid dose during intercurrent illness. The response of patients concerning medication during two hypothetical situations was documented: (a) if they were unwell with a fever; and (b) if they were vomiting and unable to take their tablets. Patients were also asked whether they were concerned about side effects from their steroid therapy, irrespective of whether given as replacement therapy or in pharmacological doses. If the patient had cognitive impairment and was accompanied by a carer (their spouse/parent) then the questionnaire was completed jointly.
Results
The results of this study are shown in Tables I-III . In addition we found that 39% of patients on long-term therapeutic corticosteroids and 23% of patients on replacement corticosteroids expressed concern about side effects, most usually weight gain and osteoporosis.
Discussion
Although almost all patients can remember receiving a steroid warning card, the overall percentage of these patients who were carrying their card was 66%, with greater compliance seen in those patients taking therapeutic steroids. This overall figure is disappointingly low, since greater compliance was found in a survey of steroid card compliance amongst rheumatoid arthritis patients in 1977. 7 Medic Alert pendants represent an effective way of conveying important information if the patient is unconscious. However, they are currently retailed in the United Kingdom at a minimum of £26.60 and in our study only 50% of owners were actually wearing their pendant at interview.
Our study suggests that many patients, particularly those on therapeutic corticosteroids, cannot recall ever being advised regarding corticosteroid requirements during intercurrent illness; this is reflected in the low percentage of appropriate patient responses when faced with an hypothetical illness or vomiting. This may in some cases be a consequence of the primary pathology and resulting therapy (which may have included neurosurgical intervention), though cognitive function was not specifically assessed during this study.
This study reveals that a significant proportion of patients on long-term corticosteroids fail to increase the dose ofthese drugs during intercurrent illness and also fail to seek medical advice and/or parenteral corticosteroids if vomiting. This is of concern since patients on replacement corticosteroids have by definition an impaired or absent glucocorticoid response to stress, and an unknown proportion of patients on long-term therapeutic corticosteroids will have adrenal suppression and a similarly impaired response to stress. A proportion ofpatients may be reluctant to increase their corticosteroids, even in the short term, for fear of side effects -even though they should not occur in those patients on replacement doses. Demonstration of lack of patient knowledge in this important area emphasizes the need for continuing, effective, education during follow-up. Patients attending our endocrine clinic are given a vial of hydrocortisone to keep at home for use by a relative or medical attendant in an emergency. As a result ofthe findings obtained during this study and in order to reinforce verbal advice given at followup clinics,we have also produced a patient information sheet (Figure 1 ) detailing the required action to be taken during intercurrent illness and vomiting.
PATIENT I.D. TR EATM ENT: DATE COMMENCED:
In the event of any illness/infection you must DOUBLE your daily steroid dose for THREE DAYS In the event of vomiting or being unable to swallow your steroid medication you must SEEK MEDICAL ADVICE EARLY since you will require a steroid injection.
Please show this sheet to any medical attendant. 
